Patients receiving regional continuous renal replacement therapy anticoagulation with heparin and protamine were more likely to experience circuit clotting than those receiving citrate and calcium ( hazard ratio , 2.03 [ 1.36-3 .03 ] ; p < 0.0005 ; 857 circuits ) .